Showing results (391-400 of 536) with videos related to
Sort By:
Pageof 54
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 23, 2016
Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohortEster Cerin, Stephanie R Rainey-Smith, David Ames, et al.The British Journal of Nutrition|September 19, 2015
Comparative analysis of the Cancer Council of Victoria and the online Commonwealth Scientific and Industrial Research Organisation FFQSamantha L Gardener, Stephanie R Rainey-Smith, S Lance Macaulay, et al.Journal of Alzheimer'S Disease : JAD|September 14, 2020
Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's DiseaseYen Ying Lim, Paul Maruff, Naoki Kaneko, et al.International Journal of Geriatric Psychiatry|April 27, 2016
Amyloid burden and incident depressive symptoms in cognitively normal older adultsKarra D Harrington, Emma Gould, Yen Ying Lim, et al.Alzheimer'S & Dementia (New York, N. Y.)|December 5, 2017
A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE studyVictor L Villemagne, Christopher C Rowe, Kevin J Barnham, et al.Neurobiology of Aging|October 6, 2023
Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's diseaseYing Xia, Paul Maruff, Vincent Doré, et al.International Psychogeriatrics|July 23, 2013
The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCIKarra D Harrington, Yen Ying Lim, Kathryn A Ellis, et al.The Journal of Prevention of Alzheimer'S Disease|March 22, 2016
The Feasibility of At-Home iPad Cognitive Testing For Use in Clinical TrialsDorene M Rentz, Maria Dekhtyar, Julia Sherman, et al.JAMA Psychiatry|January 29, 2015
Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort studyRobert H Pietrzak, Yen Ying Lim, Alexander Neumeister, et al.Alzheimer Disease and Associated Disorders|March 22, 2018
Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 YearsNicholas I Bradfield, Kathryn A Ellis, Greg Savage, et al.Pageof 54